Li, Y., Wang, R., A, J., Sun, R., Na, S., Liu, T., . . . Ge, W. (2022). Cerebrospinal fluid metabolic profiling reveals divergent modulation of pentose phosphate pathway by midazolam, propofol and dexmedetomidine in patients with subarachnoid hemorrhage. BMC Anesthesiology, 22(1), 1. https://doi.org/10.1186/s12871-022-01574-z
Chicago-referens (17:e uppl.)Li, Yi-Chen, Rong Wang, Ji-Ye A, Run-Bin Sun, Shi-Jie Na, Tao Liu, Xuan-Sheng Ding, och Wei-Hong Ge. "Cerebrospinal Fluid Metabolic Profiling Reveals Divergent Modulation of Pentose Phosphate Pathway by Midazolam, Propofol and Dexmedetomidine in Patients with Subarachnoid Hemorrhage." BMC Anesthesiology 22, no. 1 (2022): 1. https://doi.org/10.1186/s12871-022-01574-z.
MLA-referens (9:e uppl.)Li, Yi-Chen, et al. "Cerebrospinal Fluid Metabolic Profiling Reveals Divergent Modulation of Pentose Phosphate Pathway by Midazolam, Propofol and Dexmedetomidine in Patients with Subarachnoid Hemorrhage." BMC Anesthesiology, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12871-022-01574-z.
